9.25
price up icon1.98%   0.18
after-market アフターアワーズ: 9.39 0.14 +1.51%
loading
前日終値:
$9.07
開ける:
$9.14
24時間の取引高:
444.85K
Relative Volume:
0.95
時価総額:
$171.38M
収益:
$1.54M
当期純損益:
$-84.53M
株価収益率:
-1.5909
EPS:
-5.8145
ネットキャッシュフロー:
$-73.65M
1週間 パフォーマンス:
+12.12%
1か月 パフォーマンス:
+22.68%
6か月 パフォーマンス:
+17.53%
1年 パフォーマンス:
+19.35%
1日の値動き範囲:
Value
$9.08
$9.49
1週間の範囲:
Value
$8.21
$9.49
52週間の値動き範囲:
Value
$7.12
$20.56

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Name
名前
Corbus Pharmaceuticals Holdings Inc
Name
セクター
Healthcare (1098)
Name
電話
617-963-0103
Name
住所
500 RIVER RIDGE DRIVE, NORWOOD, MA
Name
職員
36
Name
Twitter
@corbuspharma
Name
次回の収益日
2026-08-04
Name
最新のSEC提出書
Name
CRBP's Discussions on Twitter

Compare CRBP vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
CRBP icon
CRBP
Corbus Pharmaceuticals Holdings Inc
9.25 173.79M 1.54M -84.53M -73.65M -5.8145
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
528.04 126.07B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
654.27 65.37B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
939.68 57.70B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
312.78 40.19B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
189.24 39.82B 742.00K -1.37B -1.07B -7.0731

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-30 再開されました B. Riley Securities Buy
2025-02-28 開始されました William Blair Outperform
2024-12-02 開始されました Piper Sandler Overweight
2024-07-30 開始されました Wedbush Outperform
2024-07-22 再開されました H.C. Wainwright Buy
2024-06-26 開始されました B. Riley Securities Buy
2024-06-03 繰り返されました Oppenheimer Outperform
2024-05-13 開始されました RBC Capital Mkts Outperform
2024-03-06 アップグレード Jefferies Hold → Buy
2020-09-08 ダウングレード BTIG Research Buy → Neutral
2020-09-08 ダウングレード Jefferies Buy → Hold
2020-09-08 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2020-09-08 ダウングレード ROTH Capital Buy → Neutral
2020-07-07 開始されました ROTH Capital Buy
2020-06-17 開始されました BTIG Research Buy
2020-03-26 開始されました Nomura Buy
2019-04-05 開始されました Jefferies Buy
2019-03-20 開始されました Oppenheimer Outperform
2019-01-11 繰り返されました Cantor Fitzgerald Overweight
2018-12-26 開始されました H.C. Wainwright Buy
2018-12-07 開始されました RBC Capital Mkts Outperform
2018-10-24 開始されました B. Riley FBR Buy
2018-01-19 開始されました Raymond James Outperform
2017-12-14 繰り返されました Cantor Fitzgerald Overweight
2017-11-08 繰り返されました Noble Financial Buy
2017-09-29 再開されました Noble Financial Buy
2017-03-30 繰り返されました Cantor Fitzgerald Overweight
2016-11-15 繰り返されました JMP Securities Mkt Outperform
2016-11-11 繰り返されました Noble Financial Buy
すべてを表示

Corbus Pharmaceuticals Holdings Inc (CRBP) 最新ニュース

pulisher
Jul 01, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Jul 01, 2026
pulisher
Jun 30, 2026

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Jun 30, 2026
pulisher
Jun 30, 2026

(CRBP) Risk Channels and Responsive Allocation - Stock Traders Daily

Jun 30, 2026
pulisher
Jun 29, 2026

Corbus Pharmaceuticals Holdings, Inc.(NasdaqCM: CRBP) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Corbus Pharmaceuticals Holdings, Inc.(NasdaqCM:CRBP) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

CRBP Q1 2026 Earnings: EPS Beats Estimates Amid Pipeline ProgressAnalyst Consensus Shift - dars.gov.et

Jun 29, 2026
pulisher
Jun 29, 2026

Corbus Pharmaceuticals Holdings, Inc.(NasdaqCM: CRBP) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 28, 2026

Corbus Pharmaceuticals Holdings, Inc.(NasdaqCM:CRBP) added to Russell Small Cap Comp Value Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 26, 2026

CRBP Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

Enterprise value to revenue forward of Corbus Pharmaceuticals Holdings, Inc. – NASDAQ:CRBP - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Price to sales forward of Corbus Pharmaceuticals Holdings, Inc. – NASDAQ:CRBP - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Enterprise value to EBIT forward of Corbus Pharmaceuticals Holdings, Inc. – BOATS:CRBP - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Corbus Pharmaceuticals (CRBP) Short Interest & Short Float | Updated Jun 2026 - MarketBeat

Jun 25, 2026
pulisher
Jun 24, 2026

Corbus Pharmaceuticals Holdings Inc (CRBP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 24, 2026
pulisher
Jun 23, 2026

CRBP Maintained by Mizuho -- Price Target Lowered to $34 - GuruFocus

Jun 23, 2026
pulisher
Jun 23, 2026

Mizuho Securities Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Cuts Target Price to $34 - Moomoo

Jun 23, 2026
pulisher
Jun 23, 2026

Corbus Pharmaceuticals Holdings Inc (CRBP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 23, 2026
pulisher
Jun 22, 2026

Corbus Pharmaceuticals Holdings Inc (CRBP) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 22, 2026
pulisher
Jun 19, 2026

(CRBP) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Jun 19, 2026
pulisher
Jun 18, 2026

Corbus Pharmaceuticals Holdings Inc (CRBP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Corbus Pharmaceuticals Holdings Inc - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Corbus Pharmaceuticals Holdings Inc (CRBP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

CRBP News | CORBUS PHARMACEUTICALS HOLDI (NASDAQ:CRBP) - ChartMill

Jun 18, 2026
pulisher
Jun 18, 2026

Corbus Pharmaceuticals Sharesanalyst consensus snapshot - AD HOC NEWS

Jun 18, 2026
pulisher
Jun 18, 2026

Corbus Pharmaceuticals Holdings Inc (CRBP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Corbus Pharmaceuticals Holdings Inc (CRBP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Corbus Pharmaceuticals Holdings Inc (CRBP) Institutional Confidence - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 18, 2026
pulisher
Jun 18, 2026

Oppenheimer Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Cuts Target Price to $52 - Moomoo

Jun 18, 2026
pulisher
Jun 17, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

Jun 17, 2026
pulisher
Jun 17, 2026

Oppenheimer Adjusts PT on Corbus Pharmaceuticals to $52 From $54, Maintains Outperform Rating - marketscreener.com

Jun 17, 2026
pulisher
Jun 17, 2026

Oppenheimer cuts Corbus Pharmaceuticals stock price target to $52 By Investing.com - Investing.com Nigeria

Jun 17, 2026
pulisher
Jun 17, 2026

Oppenheimer cuts Corbus Pharmaceuticals stock price target to $52 - Investing.com

Jun 17, 2026
pulisher
Jun 16, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Jun 16, 2026
pulisher
Jun 15, 2026

Corbus Pharmaceuticals Holdings Inc. stock rises Monday, still underperforms market - MarketWatch

Jun 15, 2026
pulisher
Jun 15, 2026

Corbus Pharmaceuticals Stock (US21833E1038): Nasdaq price action in focus on a quiet news day - Ad-hoc-news.de

Jun 15, 2026
pulisher
Jun 11, 2026

Corbus Pharmaceuticals Holdings Inc. stock rises Thursday, still underperforms market - MarketWatch

Jun 11, 2026
pulisher
Jun 11, 2026

Corbus Pharmaceuticals (CRBP) director sells 2,026 shares under 10b5-1 plan - Stock Titan

Jun 11, 2026
pulisher
Jun 11, 2026

Corbus (NASDAQ: CRBP) director sells 2,412 shares under 10b5-1 plan - Stock Titan

Jun 11, 2026
pulisher
Jun 11, 2026

Corbus (CRBP) director Jenkins sells 4,800 shares in Rule 10b5-1 trade - Stock Titan

Jun 11, 2026
pulisher
Jun 10, 2026

Corbus Pharmaceuticals teases cancer, obesity data as key clinical readouts near - MSN

Jun 10, 2026
pulisher
Jun 09, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Jun 09, 2026
pulisher
Jun 09, 2026

Corbus Pharmaceuticals targets HPV-linked head and neck cancer with CRB-701 study - MSN

Jun 09, 2026
pulisher
Jun 09, 2026

Corbus Pharmaceuticals Teases Cancer, Obesity Data as Key Clinical Readouts Near - Yahoo Finance

Jun 09, 2026
pulisher
Jun 08, 2026

Liquidity Mapping Around (CRBP) Price Events - Stock Traders Daily

Jun 08, 2026
pulisher
Jun 08, 2026

Insider Spends US$101k Buying More Shares In Corbus Pharmaceuticals Holdings - simplywall.st

Jun 08, 2026
pulisher
Jun 05, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch

Jun 05, 2026
pulisher
Jun 04, 2026

CRBP: Lead oncology and obesity assets advance with pivotal data and strong financial runway - TradingView

Jun 04, 2026
pulisher
Jun 04, 2026

CRBP Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Jun 04, 2026
pulisher
Jun 03, 2026

Corbus Pharmaceuticals CBO Nishant Saxena buys $101,218 in stock By Investing.com - Investing.com Australia

Jun 03, 2026
pulisher
Jun 03, 2026

Corbus Pharmaceuticals CBO Nishant Saxena buys $101,218 in stock - Investing.com

Jun 03, 2026

Corbus Pharmaceuticals Holdings Inc (CRBP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Corbus Pharmaceuticals Holdings Inc (CRBP) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Altmeyer Anne
Director
Jun 10 '26
Sale
7.91
2,412
19,088
7,579
Jenkins John Kenneth
Director
Jun 10 '26
Sale
7.91
4,800
37,986
3,833
Saxena Nishant C
Chief Business Officer
Jun 03 '26
Buy
7.58
9,000
68,220
75,300
Saxena Nishant C
Chief Business Officer
Jun 02 '26
Buy
7.33
4,500
32,998
66,300
Smethurst Dominic
Chief Medical Officer
Mar 02 '26
Sale
8.30
6,097
50,601
89,790
$97.55
price up icon 3.86%
$35.13
price up icon 0.29%
$57.77
price up icon 3.57%
ONC ONC
$297.65
price up icon 2.38%
$79.76
price up icon 10.01%
$189.24
price up icon 0.92%
大文字化:     |  ボリューム (24 時間):